1. |
Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives [J]. Biochim Biophys Acta, 1998, 1378(2): F115F177.
|
2. |
Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer [J]. J Clin Oncol, 1998, 16(3): 11971206.
|
3. |
Rocco JW, Sidransky D. p16(MTS1/CDKN2/INK4a) in cancer progression [J]. Exp Cell Res, 2001, 264(1): 4255.
|
4. |
Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers [J]. Nat Med, 1995, 1(7): 686692.
|
5. |
Zhao Y, Zhang S, Fu B, et al. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas [J]. Cancer Genet Cytogenet, 1999, 112(1): 2633.
|
6. |
Serrano M, Hannon GJ, Beach D. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4 [J]. Nature, 1993, 366(6456): 704707.
|
7. |
杨金巧, 周蕾蕾, 赵俊玲. p16蛋白在乳腺癌中的表达及其临床意义 [J]. 中国普外基础与临床杂志, 2000, 7(5): 297298.
|
8. |
Bohn OL, FuertesCamilo M, Navarro L, et al. p16INK4a expression in basallike breast carcinoma [J]. Int J Clin Exp Pathol, 2010, 3(6): 600607.
|
9. |
Hinshelwood RA, Melki JR, Huschtscha LI, et al. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning [J]. Hum Mol Genet, 2009, 18(16): 30983109.
|
10. |
Witcher M, Emerson BM. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary [J]. Mol Cell, 2009, 34(3): 271284.
|
11. |
DeInnocentes P, Agarwal P, Bird RC. Phenotyperescue of cyclindependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer [J]. J Cell Biochem, 2009,106(3): 491505.
|
12. |
Vallian S, Sedaghat M, Nassiri I, et al. Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer [J]. J Cancer Res Clin Oncol, 2009, 135(8): 991996.
|
13. |
Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers [J].Cancer Res, 1995, 55(20): 45254530.
|
14. |
郭山春, 廖松林, 孟振行, 等. 乳腺癌P16 基因的纯合缺失、高甲基化、突变及其表达 [J]. 中华病理学杂志, 1999, 28(2): 105108.
|